Sphingolipid Metabolism in Systemic Inflammation

por Deigner, H. P., Gulbins, E., Claus, R. A.
Publicado 2007

Sphingolipid Metabolism in Systemic Inflammation

por Deigner, H. P., Gulbins, E., Claus, R. A.
Publicado 2007

Early effects of the antineoplastic agent salinomycin on mitochondrial function

por Managò, A, Leanza, L, Carraretto, L, Sassi, N, Grancara, S, Quintana-Cabrera, R, Trimarco, V, Toninello, A, Scorrano, L, Trentin, L, Semenzato, G, Gulbins, E, Zoratti, M, Szabò, I
Publicado 2015

Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study

por Hoertel, N., Sánchez-Rico, M., Gulbins, E., Kornhuber, J., Vernet, R., Beeker, N., Neuraz, A., Blanco, C., Olfson, M., Airagnes, G., Lemogne, C., Alvarado, J. M., Arnaout, M., Cougoule, C., Meneton, P., Limosin, F.
Publicado 2022

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19

por Hoertel, N., Sanchez-Rico, M., Kornhuber, J., Gulbins, E., Reiersen, A., Lenze, E., Fritz, B. A., Jalali, F., Mills, E., Cougoule, C., Carpinteiro, A., Mühle, C., Becker-Flegler, K. A., Boulware, D. R., Blanco, C., Alvarado, J. M., Strub-Wourgaft, N., Lemogne, C., Limosin, F.
Publicado 2023

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model

por Péricat, D., Leon-Icaza, S. A., Sánchez-Rico, M., Mühle, C., Zoicas, I., Schumacher, F., Planès, R., Mazars, R., Gros, G., Carpinteiro, A., Becker, K. A., Izopet, J., Strub-Wourgaft, N., Sjö, P., Neyrolles, O., Kleuser, B., Limosin, F., Gulbins, E., Kornhuber, J., Meunier, E., Hoertel, N., Cougoule, C.
Publicado 2023